Orbimed Advisors - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 156 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2021$28,713,000
-42.4%
848,503
-29.7%
0.29%
-37.8%
Q1 2021$49,844,000
-10.2%
1,206,886
-5.7%
0.47%
-4.1%
Q4 2020$55,530,000
+109.3%
1,280,086
+106.9%
0.49%
+45.5%
Q3 2020$26,537,000
+137.4%
618,586
+158.6%
0.33%
+112.7%
Q2 2020$11,180,000239,1860.16%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 253,300$6,829,0007.22%
Integral Health Asset Management, LLC 125,000$3,370,0000.88%
Green Alpha Advisors, LLC 23,013$620,0000.42%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 24,915$672,0000.41%
Nikko Asset Management Americas, Inc. 1,402,078$37,856,0000.28%
ARK Investment Management 2,383,840$64,268,0000.27%
FEDERATED HERMES, INC. 3,761,900$101,421,0000.23%
PDT Partners, LLC 49,500$1,335,0000.12%
NinePointTwo Capital LLC 12,417$334,0000.09%
Hennion & Walsh Asset Management, Inc. 59,385$1,601,0000.08%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders